AIDS Treatment News logo      

December 24, 2010

Nevirapine rather than efavirenz-based HIV treatment more likely to suppress viral load to zero

Aidsmap: "The inclusion of nevirapine rather than efavirenz in an HIV treatment combination was more likely to suppress viral load in the blood to completely undetectable levels, French investigators report in the online edition of AIDS.

"A total of 81% of patients taking nevirapine (Viramune) had a viral load below 1 copy/ml compared to 55% of individuals treated with efavirenz (Sustiva). The study involved 165 patients and was retrospective. All the patients had had an undetectable viral load for at least six months and were taking either nevirapine or efavirenz in combination with FTC (emtricitabine, Emtriva) and tenofovir (Viread, the two drugs are usually combined in a single pill, Truvada, and are also available co-formulated with efavirenz in Atripla)."